#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12732	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2160	581.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	711	C,A	692,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3527	671.7	0	.	n	.	0	T695C	SNP	695	695	T	1058	1058	C	735	C	718	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3527	671.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1700	1700	A	762	A,G	750,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3527	671.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2334	2334	C	746	C	722	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3527	671.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2408	2408	A	732	A,T	711,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3527	671.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2960	2960	C	714	C,T	703,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	V36A	NONSYN	106	108	GTG	476	478	GCG	176;177;178	G;C;G	173;174;175	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	518	520	CGG	162;159;159	C;G;G	156;155;154	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	S68L	NONSYN	202	204	TCG	572	574	TTG	137;137;135	T,C;T,C,G;G	126,1;134,1,1;133	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	A90V	NONSYN	268	270	GCG	638	640	GTT	133;131;128	G;T,G;T	131;117,1;128	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	I105V	NONSYN	313	315	ATT	683	685	GTT	133;131;130	G;T,G;T	131;120,1;128	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	N125T	NONSYN	373	375	AAT	743	745	ACC	158;155;152	A;C;C	150;148;151	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	R135C	NONSYN	403	405	CGT	773	775	TGT	172;174;169	T,C,G;G;T,C,G	156,2,1;171;154,2,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	K151E	NONSYN	451	453	AAA	821	823	GAA	144;145;146	G,A;A;A	142,1;143;144	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	824	826	AAC	146;148;148	A;A,C;C	145;146,1;146	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	A172T	NONSYN	514	516	GCG	884	886	ACA	122;124;124	A;C;A	118;122;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	A175E	NONSYN	523	525	GCG	893	895	GAA	126;127;130	G;A;A	123;125;126	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	E176T	NONSYN	526	528	GAA	896	898	ACC	130;129;131	A;C;C	123;128;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	I178V	NONSYN	532	534	ATC	902	904	GTC	123;123;120	G;T,C;C	119;118,1;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	I188T	NONSYN	562	564	ATA	932	934	ACG	136;137;137	A;C,T;G	130;128,1;129	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	P200N	NONSYN	598	600	CCC	968	970	AAC	123;124;125	A;A;C	120;118;120	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1028	1030	TTG	134;133;130	T;T;G	131;131;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1085	1087	ACC	111;112;111	A;C;C	109;109;107	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1088	1090	GAC	112;113;115	G;A;C	111;105;113	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1097	1099	GCG	110;106;105	G;C,A;G	107;90,1;102	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1133	1135	GCT	100;105;107	G;C;T	97;99;100	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1420	folP	858	858	91.61	folP.l6.c30.ctg.1	1567	89.7	1	SNP	p	R230S	1	.	.	688	690	AGC	1058	1060	AGC	135;135;133	A;G;C	134;135;131	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3387	141.2	1	SNP	p	S91F	0	.	.	271	273	TCC	577	579	TCC	168;169;169	T;C,T;C	166;167,1;168	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3387	141.2	1	SNP	p	D95G	0	.	.	283	285	GAC	589	591	GAC	166;167;169	G;A,G;C	165;162,1;165	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4816	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3387	141.2	1	SNP	p	D95N	0	.	.	283	285	GAC	589	591	GAC	166;167;169	G;A,G;C	165;162,1;165	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1474	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1416	103.4	1	SNP	p	G45D	1	.	.	133	135	GAC	536	538	GAC	175;177;174	G;A;C	172;172;170	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	728	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1081	66.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4458	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	145.6	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	169;168;172	G;A,G,T;C	165;157,1,1;169	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4458	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	145.6	1	SNP	p	S87R	0	.	.	259	261	AGT	591	593	AGT	173;172;173	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4458	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	145.6	1	SNP	p	S87I	0	.	.	259	261	AGT	591	593	AGT	173;172;173	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4458	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	145.6	1	SNP	p	S87W	0	.	.	259	261	AGT	591	593	AGT	173;172;173	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4458	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3040	145.6	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	174;174;175	T;C;C	169;171;172	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3264	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2571	125.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1525	1527	GGC	164;164;164	G;G;C	163;162;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1300	1302	GCC	189;190;193	G,A;C,G;C	185,1;188,1;188	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1303	1305	ATG	191;190;189	A;T;G	188;186;185	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1315	1317	ACC	188;186;188	A;C;C	182;184;182	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1315	1317	ACC	188;186;188	A;C;C	182;184;182	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1816	1818	ACC	162;164;163	A;C;C	150;162;160	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1870	1872	GCG	163;162;162	G;C;G	163;158;161	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1870	1872	GCG	163;162;162	G;C;G	163;158;161	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1993	1995	GGT	115;115;113	G,A;G;T,C	112,1;111;106,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2002	2004	AGC	106;107;105	A,G,C;G;C,G	98,1,1;104;97,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3372	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2470	135.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2020	2022	CCG	84;84;85	C,G;C;G	77,1;72;72	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4880	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3182	151.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1781	1783	CTG	157;157;155	C;T;G,T	147;146;147,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2004	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2101	94.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	766	766	C	140	C,G	129,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	65	67	TTA	37;38;38	T;T;A	37;38;38	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	110	112	CAT	36;35;34	C;A;T	35;33;34	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	113	115	AGT	34;34;34	A;G;T	34;34;34	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	122	124	TAC	34;34;34	T;A;C	34;34;34	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	212	214	GAA	9;11;11	G;A;A	9;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	224	226	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	233	235	ATC	12;12;12	A;T;C	12;12;12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	239	241	TCG	11;11;10	T;C;G	11;11;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	245	247	GCC	9;8;8	G;C;C	9;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	248	250	AGC	8;8;8	A;G;C	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	251	253	GCC	8;8;8	G;C;C	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	407	20.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	257	259	GTT	10;10;10	G;T;T	10;10;10	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2496	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1759	140.7	0	.	p	.	0	E41K	NONSYN	121	123	GAA	460	462	AAA	180;178;179	A;A;A	175;175;176	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2496	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1759	140.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	970	970	T	205	T,A	190,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2496	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1759	140.7	1	SNP	p	G120K	0	.	.	358	360	GGT	697	699	GGT	185;185;186	G;G;T	179;182;176	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2496	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1759	140.7	1	SNP	p	A121D	0	.	.	361	363	GCC	700	702	GCC	182;181;183	G;C;C	177;178;182	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2496	porB1b	1035	1035	98.66	porB1b.l15.c30.ctg.1	1759	140.7	1	SNP	p	A121N	0	.	.	361	363	GCC	700	702	GCC	182;181;183	G;C;C	177;178;182	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8602	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5032	169.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2123	2125	CAT	186;187;186	C;A;T	185;185;184	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1110	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1146	96.2	1	SNP	p	V57M	1	.	.	169	171	ATG	564	566	ATG	211;212;213	A;T;G	208;206;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
